Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

CairnSurgical Breast Cancer Locator (BCL) Post-Market Study

NCT: NCT06461663 · COMPLETED

NCT IDNCT06461663
StatusCOMPLETED
Start Date2022-06-22
Completion2024-04-19
SponsorCairnSurgical, Inc. (INDUSTRY)
First posted
Last updated

Brief Summary

This interventional, post-market, multicenter clinical investigation is designed to evaluate the performance of a custom-made medical device, "the Breast Cancer Locator (BCL)" in Subjects with non-palpable breast cancer, in Europe.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.

↑